An Editorial by Dr. Raquel Peyraube   An important issue surrounding cannabis-based treatments is how they are administered. Routes of administration depend on several factors

An Editorial by Dr. Raquel Peyraube   Continuing with the discussion on general aspects of cannabis and cannabinoid treatments, let’s look at two practical issues when implementing them.   The effectiveness of

An Editorial by Dr. Raquel Peyraube   Given that endocannabinoid system (ECS) receptors are distributed throughout the body, the effects and therapeutic uses of cannabis

EDITORIAL BY STEFAN MARTIN MEYER Over 500 participants from 35 countries came together in Berlin, Germany for the 10th edition of the International Association for Cannabinoid Medicines (IACM)

EDITORIAL BY DR. RAQUEL PEYRAUBE For more than 30 years, scientific research has been conducted on the effects of cannabis and cannabinoids on the human

On September 26, 2019 John Mavridis, Plena Global’s SVP of Corporate Development, was the keynote speaker at “IP Seminar: Protecting Cannabis and Artificial Intelligence,” an

Last week, Plena Global’s Director of Public Policy and Health, Dr. Raquel Peyraube, spoke about the definitions and concepts surrounding medical grade cannabis at the

On August 4th, Plena Global CEO Richard Zwicky participated on a panel at the U.S. Cannabis Conference and Expo in Miami, Florida discussing “Investing in

It is now in the hands of the United Nations to vote on the recommendations put forth by the WHO to reschedule cannabis On January

With 95-years of prohibition, there is very little that we know about cannabis due to restrictive research—most of it from short-term studies and anecdotal observation.